Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

TEVA-EFAVIRENZ

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is TEVA-EFAVIRENZ discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that TEVA-EFAVIRENZ 600MG has been permanently discontinued (last updated April 29, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is TEVA-EFAVIRENZ not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength600MG
Last updated2025-04-29

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MYLAN-EFAVIRENZ

MYLAN PHARMACEUTICALS ULC

600MG · DIN 02381524

Same strengthSame dosage formSame routeNo current shortage

JAMP-EFAVIRENZ

JAMP PHARMA CORPORATION

600MG · DIN 02458233

Same strengthSame dosage formSame routeNo current shortage

AURO-EFAVIRENZ

AURO PHARMA INC

600MG · DIN 02418428

Same strengthSame dosage formSame routeNo current shortage

Other Products

SUSTIVA 100MG

BRISTOL-MYERS SQUIBB CANADA

100MG · DIN 02239887

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02389762

Strength

600MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

EFAVIRENZ

See all EFAVIRENZ products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History